SEC Form 4 · accession 0001127602-18-030496
Encompass Health Corp · EHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Jr D D S Maupin
Director
Period of report
Oct 15, 2018
Accepted (ET)
Oct 17, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000785161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Encompass Health Common StockF1 | Oct 15, 2018 | A | 238 | $0.00 | A | 70,766 | D | |
| Encompass Health Common StockF2,F3 | Oct 16, 2018 | A | 7 | $75.32 | A | 70,773 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
- F2Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On October 15, 2018, the Company paid a dividend on common stock of $0.27 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.
- F3This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.29 to $75.32, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.